Initiation of Section 301 Investigation; Hearing; and Request for Public Comments: Germany's Persistent Underpayment for Innovative Pharmaceutical Products
Trade Representative, Office of United States · Notice
Summary
The United States Trade Representative (U.S. Trade Representative) has initiated an investigation pursuant to the Trade Act of 1974, as amended (Trade Act), with respect to Germany's persistent underpayment for innovative pharmaceutical products. The inter-agency Section 301 Committee is holding a public hearing and seeking public comments in connection with this investigation.
Affected frameworks & controls
No framework controls are mapped to this item yet.
Key dates
- Status
- Active
- Category
- HealthcareHIPAA
- Published
- Jun 24, 2026
- Effective
- —
- Comments close
- —
View source document Download PDF